title: The trophoblastic epithelial barrier is not infected in full-term placentae of human immunodeficiency virus-seropositive mothers undergoing antiretroviral therapy.
abstract: To study the mechanism of the placental barrier function, we examined 10 matched samples of term placentae, cord blood, and maternal blood obtained at delivery from human immunodeficiency virus (HIV)-infected mothers with children diagnosed as HIV negative in Sweden. All placentae were histologically normal, and immunochemistry for HIV type 1 p24 and gp120 antigens was negative. Highly purified trophoblasts (93 to 99% purity) were negative for HIV DNA and RNA, indicating that the trophoblasts were uninfected. Although HIV DNA was detected in placenta-derived T lymphocytes and monocytes, microsatellite analysis showed that these cells were a mixture of maternal and fetal cells. Our study indicates that the placental barrier, i.e., the trophoblastic layer, is not HIV infected and, consequently, HIV infection of the fetus is likely to occur through other routes, such as breaks in the placental barrier.
authors.affiliation: Microbiology and Tumorbiology Center, Karolinska Institute, Huddinge Hospital, Karolinska Institute.
authors.forename: C
authors.initials: C
authors.lastname: Tscherning-Casper
authors.forename: N
authors.initials: N
authors.lastname: Papadogiannakis
authors.forename: M
authors.initials: M
authors.lastname: Anvret
authors.forename: L
authors.initials: L
authors.lastname: Stolpe
authors.forename: S
authors.initials: S
authors.lastname: Lindgren
authors.forename: A B
authors.initials: AB
authors.lastname: Bohlin
authors.forename: J
authors.initials: J
authors.lastname: Albert
authors.forename: E M
authors.initials: EM
authors.lastname: Fenyö
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D004279:DNA, Viral / Q000032:analysis; D004847:Epithelial Cells / Q000821:virology; D005260:Female; D005312:Fetal Blood / Q000821:virology; D006678:HIV / Q000302:isolation & purification*; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology / Q000635:transmission / Q000821:virology; D015497:HIV-1 / Q000302:isolation & purification; D015498:HIV-2 / Q000302:isolation & purification; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control; D010920:Placenta / Q000821:virology*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D012367:RNA, Viral / Q000032:analysis; D014327:Trophoblasts / Q000166:cytology / Q000821:virology*
chemical_list: D019380:Anti-HIV Agents; D004279:DNA, Viral; D012367:RNA, Viral